?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
Archives:
Resources
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
April 5, 2023
signalgroup
Biosimilars Forum Comments on BsUFA III Research Roadmap
December 20, 2022
signalgroup
Shared Savings Programs in Europe
October 4, 2022
signalgroup
Inflation Reduction Act – ASP+8 Biosimilars Payment Increase
September 26, 2022
signalgroup
Biosimilars: Non-Medical Switching and Transitioning
August 3, 2022
signalgroup
Humira® Biosimilars: Reaching the Market’s Cost-Savings Potential
June 6, 2022
signalgroup
Biosimilars 101 Webinar Case Study
June 1, 2022
signalgroup
Biosimilars Forum Comments on PBM Business Practices
April 25, 2022
signalgroup
Saving Billions on Healthcare Costs with Biosimilars
April 13, 2022
signalgroup
Biosimilars Basics
September 15, 2021
signalgroup
Separate Codes and Payment for Biosimilars
01
02
03
04